Another important distinction for Medochemie Hellas was achieved on Thursday, November 6, 2019 during the “Salus Index 2019” Business Excellence Awards organized by New Times Publishing Group.
Mr. Antonis Evmorfiades, Medochemie Hellas CEO, received the award for the company’s remarkable growth and during his speech, he highlighted the challenges of doing business in a highly negative environment for pharmaceutical companies and dedicated this distinction to the company's employees.
Deputy Minister of Health, Vassilis Kontozamanis, President of the Hellenic Association of Pharmaceutical Companies (SFEE), Olympios Papadimitriou, Special Adviser to the Panhellenic Union of Pharmaceutical Industry, Vasilis Pentafragas and the ex-Minister of Health, Panagiotis Kouroublis, also attended the event and briefly addressed the audience.
Medochemie Hellas is one of the fastest growing generic companies in Greece and a subsidiary of the global pharmaceutical company MEDOCHEMIE Ltd. With 21 affiliates worldwide and 13 manufacturing facilities, Medochemie Ltd has been specializing in developing, producing and marketing generic therapeutic solutions for over 40 years. Medochemie Hellas employs more than 60 people, and the therapeutic categories of focus include central nervous system, cardiology and pathology, with more than 30 products, covering both the private and hospital markets.
It is also worth noting that Medochemie’s donation of pharmaceutical material to social clinics and pharmacies, on a regular basis, reconfirms the company’s commitment to its values and social responsibility.